RMTG (Regenerative Medical Technology Group) Ending Cash Position: $1.32 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Regenerative Medical Technology Group Ending Cash Position?

Regenerative Medical Technology Group RMTG -19.93% Ending Cash Position is $1.32 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

Regenerative Medical Technology Group's Ending Cash Position for the quarter that ended in Jun. 2026 was $1.32 Mil.

Regenerative Medical Technology Group's quarterly Ending Cash Position increased from Dec. 2025 ($0.96 Mil) to Mar. 2026 ($1.06 Mil) and increased from Mar. 2026 ($1.06 Mil) to Jun. 2026 ($1.32 Mil).

Regenerative Medical Technology Group's annual Ending Cash Position increased from Dec. 2023 ($0.53 Mil) to Dec. 2024 ($1.17 Mil) but then declined from Dec. 2024 ($1.17 Mil) to Dec. 2025 ($0.96 Mil).

Regenerative Medical Technology Group Ending Cash Position Related Terms

Regenerative Medical Technology Group Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerative Medical Technology Group Ending Cash Position Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 2.98 1.65 0.53 1.17 0.96

Regenerative Medical Technology Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.61 1.19 0.96 1.06 1.32

Regenerative Medical Technology Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Regenerative Medical Technology Group's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.167+-0.21
=0.96

Regenerative Medical Technology Group's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.061+0.262
=1.32

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $1.32 Mil mean?
Regenerative Medical Technology Group (RMTG) has a Ending Cash Position of $1.32 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Regenerative Medical Technology Group and its competitors.
Is Regenerative Medical Technology Group's Ending Cash Position too high?
Regenerative Medical Technology Group's current Ending Cash Position is $1.32 Mil.
How does Regenerative Medical Technology Group's Ending Cash Position compare to BZYR and CLSDQ?
Regenerative Medical Technology Group's Ending Cash Position of $1.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Regenerative Medical Technology Group and its competitors. Regenerative Medical Technology Group's current Ending Cash Position is $1.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Fairly Valued. The stock's GF Value™ is $0.08, compared to a current price of $0.08 — trading 2.4% below its estimated fair value. The current Ending Cash Position is $1.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current Ending Cash Position is $1.32 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.